Concepedia
Statistics
Publications
5
Citations
193
H-Index
Active since
2011
Affiliations
Oncor (United States)(Current)
Wright State University
Terry Farkaly is an author at Oncor (United States) specializing in oncology, medicine, and molecular oncology.
Publications per year
2011–2022
ONCR-177, an Oncolytic HSV-1 Designed to Potently Activate Systemic Antitumor Immunity
Brian B. Haines, Agnieszka Denslow, Peter Grzesik et al. · Cancer Immunology Research · 2020 · 68 citations · Full text
Medicine, Immunology, Oncology +17
Development of intravenously administered synthetic RNA virus immunotherapy for the treatment of cancer
Edward M. Kennedy, Agnieszka Denslow, Jacqueline Hewett et al. · Nature Communications · 2022 · 41 citations · Full text
Life Sciences, Cancer Biology, Oncology +17
Cell Invasion of Highly Metastatic MTLn3 Cancer Cells Is Dependent on Phospholipase D2 (PLD2) and Janus Kinase 3 (JAK3)
Karen M. Henkels, Terry Farkaly, Madhu Mahankali et al. · Journal of Molecular Biology · 2011 · 32 citations
Medicine, Cell Biology, Oncology +17
Phosphatidic Acid (PA) can Displace PPARα/LXRα Binding to The EGFR Promoter Causing its Transrepression in Luminal Cancer Cells
Madhu Mahankali, Terry Farkaly, Shimpi Bedi et al. · Scientific Reports · 2015 · 27 citations · Full text
Medicine, Molecular Biology, Oncology +17
Design of an Interferon-Resistant Oncolytic HSV-1 Incorporating Redundant Safety Modalities for Improved Tolerability
Edward M. Kennedy, Terry Farkaly, Peter Grzesik et al. · Molecular Therapy — Oncolytics · 2020 · 25 citations · Full text
Life Sciences, Infectious Diseases, Oncology +17
1–5 of 5